dim changed from 15/8/78% in early childhood to 6/4/90% in adults, respectively. Within this study, we first compared the NK cell reconstitution post-HSCT to reference values of NK cell subpopulations of healthy children. Afterward, we investigated the reconstitution of NK cell subpopulations post-HSCT in correlation to acute graft versus host disease (aGvHD) and chronic graft versus host disease (cGvHD) as well as to viral infections. Interestingly, after a HSCT follow-up phase of 12 months, the distribution of NK cell subpopulations largely matched the 50th percentile of the reference range for healthy individuals. Patients suffering from aGvHD and cGvHD showed a delayed reconstitution of NK cells. Remarkably, within the first 2 months post-HSCT, patients suffering from aGvHD had significantly lower levels of CD56 bright NK cells compared to patients without viral infection or without graft versus host disease (GvHD). Therefore, the amount of CD56 bright NK cells might serve as an early prognostic factor for GvHD development. Furthermore, a prolonged and elevated peak in − subpopulation, which is mainly present in the early period post-HSCT, primarily secretes immunoregulatory cytokines. Presumably, the development from CD56 bright to CD56 dim NK cells corresponds to sequential steps of NK cell differentiation (6) . In most patients, the ratio between CD56 bright and CD56 dim NK cells normalizes within the first 6 months post-HSCT influenced by the patient's age and events following HSCT. A correlation between the reconstitution of NK cells and overall survival was described by few studies emphasizing their essential role in the defense of infections when T cell immunity is mainly absent (7, 8) . Furthermore, NK cells were successfully applied as immunotherapy for patients with highrisk malignancies suffering from impending relapse following HSCT. In clinical studies, adoptively infused NK cells induced graft-versus-leukemia/tumor effect without concomitant severe graft versus host disease (GvHD) (9) (10) (11) . In addition, recent studies ascribe GvHD reduction to NK cell function post-HSCT (12) . In this work, we focused on the regeneration of CD56 bright and CD56 dim NK cells with a special regard on the population shifting between these subpopulations. We divided NK cells in three NK cell subpopulations. In the first step, we established reference values of CD56
, and CD56 + CD16 ++ (CD56 dim ) NK cells of healthy children and adolescents (n = 174). These reference values were matched and compared to the NK cell reconstitution of patients, who did not suffer from any viral infection or GvHD and are still alive after allogenic stem cell transplantation. In the next step, we investigated the associations between the reconstitution of the three different NK cell subpopulations in regard to the occurrence of events such as acute graft versus host disease (aGvHD) or chronic graft versus host disease (cGvHD) and severe viral infections in the first year post-HSCT in contrast to a cohort of patients without severe events assumed as control group.
MaTerials anD MeThODs reference cohort of children and adolescents
In this cross-sectional monocentric study (approval ethic committee Ref.
No. 139/09), 174 donors (64 females and 110 males) were included. Residual peripheral blood samples of hematologically healthy children aged 1 month to 18 years were analyzed (patients were hospitalized, e.g., for cleft lip and palate correction). Inclusion criteria involved no incidence of immunodeficiency or infection (defined as >2 severe infections/year, >8 infections/ year, persistent fungal infections, post-vaccinal complications, no evidence of acute bleeding, negative for CRP and normal leukocytes, lymphocytes, and neutrophil granulocytes).
Patients and grafts
The reconstitution of NK cells and their subpopulation CD56 bright , CD56 int , and CD56 dim was analyzed in n = 74 patients (n = 25 females and n = 49 males) transplanted from 2010 to 2016 (see Table 1 ). Indications for HSCT were high-risk acute lymphoblastic leukemia (n = 51), acute myeloid leukemia (n = 12), and myelodysplastic syndrome (n = 11). Median age at HSCT was 10.4 years (range: 1.3-24.4 years). Grafts were received from matched family donors (MSD; n = 20), matched unrelated donors (MUD) (n = 39), and haploidentical mismatched family donors with <8/10 HLA matches (MMFD; n = 15). No significant differences in the occurrence of GvHD were available in the different donor groups (MSD: 6/20, MUD: 10/39, and MMFD: 3/15). A second or third transplant was administered to n = 9 and n = 2 patients, respectively, because of relapse after first or second HSCT. Stem cell sources consisted of (bone marrow; n = 48), unmanipulated PBSC (n = 11), and T cell-depleted PBSC (n = 15). Post-transplant aGvHD occurred in n = 31 patients with grades I (n = 9), II (n = 3), III (n = 16), and IV (n = 3), cGvHD in 22 patients. Severe viral infections occurred in 18 patients including primary infection or reactivation with cytomegalovirus (CMV) (n = 8), adenovirus (ADV) (n = 5), and Epstein-Barr virus (EBV) (n = 5).
study Design
This study was carried out in accordance with the Declaration of GvHD. In context of viral infection, a slightly lower CD56 and CD16 receptor expression followed by a considerable reduction in the absolute CD56 dim NK cell numbers combined with reoccurrence of CD56 int NK cells was observed. Our results suggest that a precise analysis of the reconstitution of NK cell subpopulations post-HSCT might indicate the occurrence of undesired events post-HSCT such as severe aGvHD. year monthly, within the second year three monthly, and afterward every 6 months until 36 months post-HSCT, respectively. In total, n = 925 measurements of n = 74 patients were included in this analysis. Depending on the occurrence of unexpected events such as aGvHD (only grades III and IV, grades I and II excluded), cGvHD, and severe viral infections, the study group was partitioned. The patient group without aGvHD/cGvHD or any viral infections was chosen for comparison as control group.
Patients showing a distinct CD56 int population in a sufficient absolute amount post-HSCT were elected for more detailed analysis applying a 10-color flow cytometry.
assessment of nK cells and Their subpopulations
Natural killer cell subpopulations were analyzed on a FC500 flow-cytometer (Beckman Coulter, Krefeld, Germany) applying a five-color panel to estimate CD3 + T cells, CD19 bright , CD56 int , and CD56 dim NK cells, respectively. Absolute cell numbers were estimated from peripheral blood samples in a dual platform lyse-no-wash procedure as described previously (13) . In brief, a tube of 100 µl EDTA-peripheral blood was labeled with CD45/CD56/CD19/ CD3 tetraCHROME (clones B3821F4A/N901/J3-119/UCHT1) multi-color mAb conjugated with FITC, phycoerythrin (PE), phycoerythrin texas red (ECD), and phycoerythrin-cyanine 5 (PC5). CD16 phycoerythrin-cyanine 7 (PC7, clone: 6607118) was additionally added. For the measurement of T cells including T helper and cytotoxic T cells, we applied the tetraCHROME multi-color reagent CD45/CD4/CD8/CD3 (clones B3821F4A/ SFCI12T4D11/SFCI21Thy2D3/UCHT1) conjugated with FITC, PE, ECD, and PC5. All reagents were acquired from Beckman Coulter Immutech (Marseille, France).
Differences in the expression profiles of CD56 bright , CD56 int , and CD56 dim cells were analyzed applying two panels on a Navios™ 10-color flow cytometer (Beckman Coulter, Krefeld, Germany). , DUMP = CD3 + CD14 + CD19 (ECD; clones: UCHT1, RMO52, J3-119), CD117 (PC5.5; clone: 104D2D1), CX3CR1 (PC7; clone: 2A9-1), CD56 (APC; clone: N901), CD62L (APC-A700; clone: DREG56), CD16 (APC-A750; clone: 3G8), CCR7 (PB; clone: G043H7), and CD45 (KrO; clone: J.33). All antibodies were purchased from Beckman Coulter Immutech except CCR5 (BD Biosciences, Heidelberg, Germany) and CX3CR1 (Biolegend, San Diego, CA, USA). Staining was performed, using 100 µl of peripheral blood for each tube followed by 15 min of incubation at room temperature and erythrocyte lysis applying NH4Cl reagent (Beckman Coulter, Marseille, France).
Stained Cyto-Comp™ cells were applied to compensate the fluorescence overlap. The flow cytometer fluidic stability and the optical alignment were daily tested using Flow-Check™ Fluorospheres (Beckman Coulter, Krefeld, Germany). For verification, Immunotrol cells (Beckman Coulter) were applied three times a day. Furthermore, we participate in an external quality assessment for the detection of T-, B-, and NK cells (INSTANT e. V.-provider for German round robin test, No 213).
Data evaluation was performed using Kaluza and CXPsoftware (Beckman Coulter).
statistical analysis
Statistical analysis was performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA). The NK subpopulation reference values of healthy children and adolescents were calculated with non-linear exponential regression analysis (equation: one-phase decay, least square fit; function: dim NK cell distribution and absolute cell counts post-HSCT, we first generated age-matched reference values of NK cell subpopulation frequencies and absolute NK cell counts for healthy children and adolescents ( Figure S1 in Supplementary Material). Interestingly, the proportion of CD56 bright , CD56 int , and CD56 dim in early childhood changed from 15, 8, and 78 to 6, 4, and 90% in adults, respectively. Subsequently, we matched the NK cell reconstitution of all patients of the control group without severe events (e.g., GvHD, infections) with the newly generated reference values (Figure 1) . The frequency of CD56 bright NK cells is elevated directly after HSCT but reaches the upper reference range following 2 months. However, the levels of CD56 bright appear slightly increased remaining between the 50th and 90th percentile until 12 months post-HSCT ( Figure 1A) . Surprisingly, the percentage of CD56 int cells matches the reference range within the first 2 months post-HSCT but increases starting from 3 months exceeding the 90th percentile of the reference range following 5 months post-HSCT. After this period, the CD56 int fraction declines and converges to the 50th percentile of the reference values 12 months after HSCT (Figure 1B) . By contrast, the CD56 dim fraction remains below the 10th percentile until 8 months and reaches the 50th percentile of normal reference values after 12 months post-HSCT ( Figure 1C) dim NK cell levels of GvHD patients remain below those of patients without events during the whole monitoring interval (c,F). Measurements were available at almost all time points, except for five patients of the aGvHD group who died 2, 3, 9, 9, and 18 months post-HSCT. values after HSCT seem to be lower than NK cells of healthy children (Figures 1D-F) .
reconstitution of nK cells with regard to gvhD Development
Patients suffering from aGvHD with grade higher than III show significant differences in the reconstitution of NK cell subpopulations compared to patients without any severe events post-HSCT. The median time of first symptoms of aGvHD was 22 days post-HSCT (range: 13-84). Within the first, second, and third month 68, 89, and 100% of the affected patients showed first signs of aGvHD, respectively. Patients without events show conspicuously higher frequency of CD56 bright NK cells within the first 3 months following HSCT compared to patients suffering from aGvHD with the most significant difference already 15 days following engraftment (p < 0.0001; Figure 2A ). This could also be shown for the absolute CD56 bright NK cell amount 1 month after HSCT (p < 0.01; Figure 2D ). This tendency was less pronounced when analyzing NK cells in patients with lower grades aGvHD (data not shown). Furthermore, the reconstitution of NK cell subpopulations seems to be delayed in patients suffering from aGvHD. For the CD56
int NK cell population, a displacement in time could be shown, which leads to a longer increase in CD56 int frequency and absolute amount (Figures 2B,E) . To reach the 50th percentile of normal reference values, patients with aGvHD need a prolonged reconstitution time taking at least two times longer compared to patients without events. Patients with lower GvHD grades were lying in between (data not shown). Even after 3 years of monitoring, a trend toward higher frequency of CD56 bright and CD56 int NK cells concomitant with lower CD56 dim was seen in patients suffering from severe aGvHD (not significant , Figures 2A-C) . These differences in the NK cell development post-HSCT were also found evaluating the absolute amounts of NK cell subpopulations (Figures 2D-F) . Noteworthy, patients affected with aGvHD following HSCT also show a reduced absolute amount of CD56 dim NK cells after 3 years post-HSCT ( Figure 2F) . Analyzing absolute NK cell count (including all three subgroups), we did not see a correlation between patients with and without aGvHD ( Figure  S2A in Supplementary Material). Analyzing cytotoxic T cells, we detected that patients reaching levels of cytotoxic T cells above 1,500/μl within the first year post-HSCT developed in almost all cases an aGvHD ( Figure S2B in Supplementary Material). But this fact was only true for less than 25% of the total aGvHD patient cohort. Furthermore, we evaluated the NK cell regeneration of int NK cells of patients suffering from cGvHD after severe acute graft versus host disease (grade III or IV) is shown for frequency (a) and absolute count (B). Over a period of at least 18 months, a higher amount of CD56 int NK cells for patients suffering from cGvHD (■, dark red squares, n = 8) was detectable compared to patients without severe events post-hematopoietic stem cell transplantation (□, green rimmed squares, n = 23). (Figure 3A) , which is also clearly visible in absolute cell count of CD56 int NK cells ( Figure 3B ). dim NK cells. As already described, we could also show that CD57 was only detectable on the CD56 dim subpopulation. Low expression of CD127 (IL7α chain), CD117 (c-Kit), and CD226 (DNAM-1) could be seen on all NK cell subpopulations; however, CD56 bright intend to have higher expression than CD56 dim , whereas CD56 int was always lying in between. In summary, the expression profiles of CD56 int and CD56 bright NK cells were nearly congruent, but differed to CD56 dim cells in KIR, CD62L, NKG2A, CX3CR1, and CD57 expression (Figure 4) .
influence of Viral infection Post-hscT on nK cell reconstitution
The immune reconstitution of NK cell subpopulations post-HSCT was analyzed in patients without events and patients suffering from ADV (n = 5), EBV (n = 5), and CMV infection (n = 8). Infection was detected by the routine analysis of DNA copies in peripheral blood. Patients with elevated viral load at the day of transplantation were excluded from the study, resulting in a cohort of patients with occurrence of a positive viral load between 30 and 90 days post-HSCT. Interestingly, we observed a slight reduction in CD56 and CD16 expression in patients suffering from viral infection in between day 30 and day 60 post-HSCT measured by mean fluorescence intensity ( Figure 5) . After viral clearance in most patients, a considerable loss in absolute CD56 dim NK cell count occurred followed by continued regeneration of CD56 int NK cells, which was lower in patients without events post-HSCT on day 150 post-HSCT ( Figure 5 ).
DiscUssiOn
Especially in the early phase following allogeneic HSCT, together with neutrophils, NK cells are the first line of immune defense. Their immune reconstitution is of crucial importance for transplantation outcome with special regard to the occurrence of GvHD and viral infections. In this project, we analyzed NK cell subpopulations in detail not only focusing on CD56 bright and CD56 dim cells but also the fraction in between those subsets. With regard to NK cell subpopulation development in young healthy Promoted by the IL-15 rich cytokine milieu post-transplant, NK cells are known to be one of the first lymphocyte subpopulation recovering post-HSCT (21) . Therefore, NK cell reconstitution might be the basis for generating early prognostic markers regarding the occurrence of severe events and transplantation outcome. Kim et al. published that NK cell counts after allo-HSCT, especially on day 30, were predictive markers for GvHD, non-relapse mortality, and survival (22) . Furthermore, there is evidence that the speed of NK cell reconstitution correlates with transplant outcome, suggesting their important role in the early period when specific T cell immunity is absent (7, 8) . Our and other findings suggest that the monitoring of NK cell subsets in the early phase post-HSCT might provide first signs of aGvHD development (23) . Interestingly, within the first 2 months post-HSCT patients without aGvHD or viral infections had significantly elevated levels of CD56 bright NK cells compared to patients suffering from aGvHD. This might be an early prognostic factor regarding GvHD development; however, it needs to be confirmed in a prospective study. Likewise results were also published by Kheav et al. showing an impaired reconstitution of CD56 dim NK cells 3 months post-HSCT (24) . We also found a comparable trend for NK cell regeneration in patients suffering from cGvHD, although not significant (data not shown). This might be explained by the fact, that for aGvHD analysis, only patients suffering from GvHD grades III and IV were considered, whereas no differentiation was available regarding cGvHD (e.g., chronification of primary aGvHD grades I and II).
Literature is discordant whether steroids/immunosuppression have a negative impact on NK cell reconstitution. Giebel et al. proposed that the use of steroids for GvHD prophylaxis negatively affects quantitative reconstitution of NK cells after allo-HSCT (25) . Although, patients suffering from GvHD grades III and IV normally receive steroids in our transplantation unit, we did not see any significant differences in the quantitative reconstitution of absolute NK cell numbers. Interestingly, Wang et (26) . This might also contribute to the delayed NK cell development in patients suffering from higher grade aGvHD that we observed within this study. However, this remains controversial as other studies analyzed the effect of CSA on NK cell function in shortterm cultures and their cytokine production without finding significant differences between NK cells with and without CSA treatment (27, 28) .
In patients suffering from viral infection post-HSCT, we observed a slight reduction in CD56 and CD16 expression. Notably, other publications already described the existence of CD56 − CD16 + NK cells (CD56 negative ) NK cells in viral infections (e.g., HIV, hepatitis C), where NK cells undergo numerous phenotypic and functional changes (29) . This CD56 negative subset has been associated with high HIV viral load and has been reported to have an impaired cytolytic function and cytokine production (30) . This increase occurred primarily at the expense of CD56 dim NK cells, whereas numbers of CD56 bright NK cells remained stable (31) . Furthermore, we observed a considerable loss in absolute CD56 dim NK cells followed by continued regeneration of CD56 int NK cells. Alteration of NK cells upon viral infection has already been shown by other research groups, for example Pical-Izard et al. showed that in patients being affected by CMV reactivation, NK cells showed lower degranulation and TNF-α production compared to patients without CMV reactivation post-HSCT (8) . In addition, it was shown that CMV reactivation is followed by an increase in the proportion of NKG2C + NK cells within 2-4 weeks, which persist for at least a year (32, 33) .
In conclusion, only after around 12 months, NK cells post-HSCT reconstitute to a distribution of the subpopulations CD56 bright , CD56 
